Harm Reduction Basics: A Practical Guide to Safer Use

Harm reduction starts from where people are. It does not ask whether someone should use a drug; it asks what would make the use they have already chosen less likely to hurt them. This page sets out where the idea comes from, the main risks of classic psychedelics as the research describes them, and what lowers each one.

For the short version, the Safety page lists the contraindications and the questions to ask any provider. If you take any medicine, the interaction checker gives the cited evidence for each medicine and substance pair, and the screening checklist covers heart, mental health and pregnancy questions. This article explains the reasoning behind them.

Where harm reduction comes from

Harm reduction entered the public health vocabulary in the 1980s as a response to HIV spreading among people who inject drugs. (Current Topics in Behavioral Neurosciences (Dyck E, Dixon J), 2026) Its early programmes grew up in the Netherlands and the United Kingdom. (Addictive Behaviors (Marlatt GA), 1996) Writing in 1996, the psychologist Alan Marlatt summed up its assumptions: it is a public health alternative to moral and criminal models of drug use, it treats abstinence as an ideal but accepts other changes that reduce harm, it grew mainly from the bottom up through drug users' own advocacy, and it favours services that are easy to reach. (Addictive Behaviors (Marlatt GA), 1996)

Two tools show how this works in practice:

• Syringe services programmes. The US Centers for Disease Control and Prevention (CDC) says nearly 30 years of research show comprehensive programmes are safe, effective and cost-saving, that they are associated with an estimated 50% reduction in HIV and hepatitis C incidence, and that they do not increase illegal drug use or crime. (US Centers for Disease Control and Prevention, 20 Mar 2024)
• Naloxone. It rapidly reverses opioid overdose, and on 29 March 2023 the FDA approved Narcan nasal spray for sale without a prescription, the first naloxone product approved that way. (US Food and Drug Administration, 29 Mar 2023)

Psychedelic communities practised risk management long before the term existed. A 2024 history traces it through the clinical trials of the 1950s and 1960s, the volunteer services at music festivals, and the ceremonies of the Native American Church. (Current Topics in Behavioral Neurosciences (Dyck E, Dixon J), 2026) Peyote is that Church's sacrament and a Vulnerable species, so this site lists no peyote ceremonies; the reasons are on the peyote position page. (IUCN Red List, 2017; eCFR, current)

What the risks actually are

For classic psychedelics (psilocybin, LSD, mescaline, DMT) the research points mostly at behaviour and mental state. A review prepared for the US scheduling process found psilocybin has limited reinforcing effects, and named the main harms as risky behaviour in unprepared, unsupervised users and the worsening of psychotic illness in people predisposed to it. (Neuropharmacology, 2018) In a US population study of more than 130,000 adults, lifetime psychedelic use was not associated with higher rates of the mental health problems measured. (PLoS ONE, 2013) That is a population average. It does not describe what happens to an individual on a bad night.

Psychological crises and risky behaviour

In a survey of 1,993 people describing their worst psilocybin mushroom experience, 11% put themselves or others at risk of physical harm, 2.6% behaved aggressively or violently and 2.7% received medical help. (Journal of Psychopharmacology, 2016) Among those whose experience was more than a year earlier, 7.6% sought treatment for lasting psychological symptoms, and risk rose with dose and with the absence of physical comfort and social support. (Journal of Psychopharmacology, 2016) The US National Institute on Drug Abuse adds that risks are greater outside clinical supervision, including driving or walking in traffic while impaired. (National Institute on Drug Abuse (NIH))

Psychosis and mania

Research safety guidelines exclude people with a personal or family history of psychotic disorders. (Journal of Psychopharmacology, 2008; Oregon Health Authority, Public Health Division, 2026) In a survey of 541 people with bipolar disorder who had used psilocybin, 32.2% described new or worse symptoms afterwards, mostly mania, sleep problems and anxiety. (Journal of Psychopharmacology, 2023)

Lasting changes in perception

Some people report visual effects returning after a trip has ended. A 2003 review of 50 years of studies called hallucinogen persisting perception disorder (HPPD) a genuine but uncommon disorder that can last months or years, reported most often after illicit LSD use and less often in research settings. (Drug and Alcohol Dependence (Halpern JH, Pope HG), 2003) In six controlled Swiss studies, 13 of 142 healthy volunteers given LSD or psilocybin reported brief, mostly mild recurrences, and none met the diagnostic criteria for HPPD. (Psychopharmacology (Muller F, Kraus E, Holze F, et al.), 2022)

Heart and blood pressure

Psilocybin typically raises blood pressure and heart rate, and NIDA says that may be dangerous for people with heart conditions. (National Institute on Drug Abuse (NIH); Psychiatry Research, 2024; EMCDDA (now EUDA), via Internet Archive snapshot 2024-06-18) In a controlled study, LSD raised heart rate more than a dose of d-amphetamine did. (Neuropsychopharmacology (Holze F, et al.), 2020) Ibogaine is a different order of risk: it prolongs the QT interval, and half the patients in one Dutch study reached a QTc over 500 ms. (Addiction, 2022) Read ibogaine clinic safety before considering it.

Falls and physical injury

Impaired coordination turns ordinary hazards into injuries. Every patient in the Dutch ibogaine study had severe temporary ataxia and could not walk without support. (Addiction, 2022) With ayahuasca, 69.9% of more than 10,000 survey respondents reported acute physical effects, mainly vomiting. (PLOS Global Public Health, 2022) Someone sober should be able to help a person to the bathroom, away from stairs, water and roads.

Knowing what you are taking

Drugs from unregulated markets carry unknown adulterants and unknown strength. (Current Topics in Behavioral Neurosciences (Hirschfeld T, et al.), 2026) Even legal Dutch truffles vary in strength from pack to pack. (DRUGSinfo (Drugs Infolijn), Trimbos-instituut)

A well-documented danger is the NBOMe family: ultrapotent compounds, often sold on blotter paper, that a 2020 review calls highly potent and toxic alternatives to LSD, with published intoxications including seizures, hyperthermia and deaths. (Frontiers in Neuroscience (Zawilska JB, Kacela M, Adamowicz P), 2020) In Melbourne, five people went to an emergency department after taking a powder sold as "powdered LSD" that turned out to contain 25B-NBOH; one had continuous seizures and needed intubation. (Clinical Toxicology (Ivory ST, et al.), 2022)

Reagent tests are cheap, quick colour tests that suggest whether an expected substance is present. A 2026 review calls them presumptive: useful for first screening, but laboratory methods such as gas or liquid chromatography with mass spectrometry give the most reliable results, and even infrared spectroscopy struggles with LSD or NBOMe on blotter paper. (Current Topics in Behavioral Neurosciences (Hirschfeld T, et al.), 2026) Drug checking services combine analysis with advice. A systematic review of 90 studies found they appear to change what people intend to do and do, particularly when a result is unexpected. (Addiction (Maghsoudi N, et al.), 2022) Testing reduces risk; it does not make an unregulated drug safe.

Medicines and other drugs

The most serious interactions involve serotonin. Ayahuasca contains MAO inhibitors, and combined with SSRI antidepressants it may cause serotonin syndrome with a potentially grave outcome. (Journal of Psychoactive Drugs, 1998; ICEERS, 2026) Lithium with a classic psychedelic was linked to seizures in 47% of 62 online reports. (Pharmacopsychiatry, 2021; Oregon Health Authority, Public Health Division, 2026) Alcohol raises the chance of a bad trip. (DRUGSinfo (Drugs Infolijn), Trimbos-instituut) The mechanisms are explained in drug interaction warnings, and ayahuasca in detail in ayahuasca and antidepressants.

Stopping a psychiatric medicine to take a psychedelic is a risk of its own. ICEERS warns that abruptly stopping psychiatric medication can be dangerous and should only happen under strict medical supervision. (ICEERS, 2018) Talk to the prescriber before changing anything.

What lowers the risk

Most of what reduces harm is ordinary planning:

• A sober companion who knows your medical history and will call for help. In the ayahuasca survey, use without supervision was associated with more physical adverse effects. (PLOS Global Public Health, 2022)
• A safe, comfortable setting. The survey of worst mushroom experiences found more risk without physical comfort and social support. (Journal of Psychopharmacology, 2016)
• Honest screening for heart disease, psychosis, bipolar disorder and medicines, using the screening checklist.
• No driving until the effects have fully passed, and no plans that depend on a clear head.
• One substance at a time. Deaths linked to ayahuasca have often involved something else, such as tobacco preparations or 5-MeO-DMT. (ICEERS, 2023)
• Not too much water. One ceremony death was due to low blood sodium from overhydration. (Nederlands Tijdschrift voor Geneeskunde, 2020; ICEERS, 2023)

A supervised programme with screening is not risk-free either, but controlled trials with inclusion criteria record few serious adverse events: nine across more than 1,000 administrations in one meta-analysis. (Psychiatry Research, 2024) Retreats do not necessarily replicate those conditions. (Psychiatry Research, 2024) Whether any of this is legal where you are is a separate question: see is it legal where I am?

When to get emergency help

Most frightening experiences pass with calm company, a quiet room and time. Some signs are medical emergencies. Warning signs of serotonin toxicity that need immediate attention include muscle jerks, extreme or fluctuating heart rate and blood pressure, severe agitation or coma, muscle rigidity, high fever and seizures. (Psychopharmacology (Berl), 2022) Treat these the same way:

• seizures, or a person who cannot be woken
• chest pain, a racing or irregular pulse, or trouble breathing
• a very high temperature, rigid muscles or confusion that is getting worse
• thoughts of self-harm, or behaviour that puts anyone in danger

Call 911 in the US or 112 in the EU and UK, and say exactly what was taken and when. Clinicians need that information to treat the right problem. In the US the Suicide and Crisis Lifeline is 988.